Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment

The presence of brain atrophy and its progression in early Parkinson's disease (PD) are still a matter of debate, particularly in patients without cognitive impairment. The aim of this longitudinal study was to assess whether PD patients who remain cognitively intact develop progressive atrophi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human brain mapping 2014-08, Vol.35 (8), p.3932-3944
Hauptverfasser: Tessa, Carlo, Lucetti, Claudio, Giannelli, Marco, Diciotti, Stefano, Poletti, Michele, Danti, Sabrina, Baldacci, Filippo, Vignali, Claudio, Bonuccelli, Ubaldo, Mascalchi, Mario, Toschi, Nicola
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3944
container_issue 8
container_start_page 3932
container_title Human brain mapping
container_volume 35
creator Tessa, Carlo
Lucetti, Claudio
Giannelli, Marco
Diciotti, Stefano
Poletti, Michele
Danti, Sabrina
Baldacci, Filippo
Vignali, Claudio
Bonuccelli, Ubaldo
Mascalchi, Mario
Toschi, Nicola
description The presence of brain atrophy and its progression in early Parkinson's disease (PD) are still a matter of debate, particularly in patients without cognitive impairment. The aim of this longitudinal study was to assess whether PD patients who remain cognitively intact develop progressive atrophic changes in the early stages of the disease. For this purpose, we employed high‐resolution T1‐weighted MR imaging to compare 22 drug‐naïve de novo PD patients without cognitive impairment to 17 age‐matched control subjects, both at baseline and at three‐year follow‐up. We used tensor‐based morphometry to explore the presence of atrophic changes at baseline and to compute yearly atrophy rates, after which we performed voxel‐wise group comparisons using threshold‐free cluster enhancement. At baseline, we did not observe significant differences in regional atrophy in PD patients with respect to control subjects. In contrast, PD patients showed significantly higher yearly atrophy rates in the prefrontal cortex, anterior cingulum, caudate nucleus, and thalamus when compared to control subjects. Our results indicate that even cognitively preserved PD patients show progressive cortical and subcortical atrophic changes in regions related to cognitive functions and that these changes are already detectable in the early stages of the disease. Hum Brain Mapp 35:3932–3944, 2014. © 2014 Wiley Periodicals, Inc.
doi_str_mv 10.1002/hbm.22449
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6868950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3365168841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6479-a7d0a6962c74ca9db6f1a75bbbfaf33db3dfc6055bb2ddccc1f63aaa63caf99c3</originalsourceid><addsrcrecordid>eNp1kt1u1DAQhSMEoqVwwQsgSwgBF2ntOHE2XCCVClpEW4r4k7ixJrazcZvYwXa27BPxmji72-VH4sojzzfnjHycJA8J3icYZwdt3e9nWZ5Xt5JdgqsyxaSit6eaFWmVl2Qnuef9JcaEFJjcTXYiW1DCst3k54Wzc6e819Yg26DagTYIgrNDu0SxDK1CCly3RD7AXPkJugB3pY235qlHUnsFXr1Ah6izZq7DKLWBDgUVAZfWsSdRb93Q2l4FN8mMcqUsFTJ2YdEAQSsTPLrWobVjQMLOjQ56oZDuB9Cuj937yZ0GOq8ebM695POb15-OTtLT98dvjw5PU8HyskqhlBhYxTJR5gIqWbOGQFnUdd1AQ6msqWwEw0W8yaQUQpCGUQBgVEBTVYLuJS_XusNY90qKaO2g44PTPbglt6D53x2jWz63C85mbFYVOAo82wg4-31UPvBee6G6Doyyo-ekyMuCzkg2oY__QS_t6OLjrShKKzzDLFLP15Rw1nunmu0yBPMpfh7j56v4I_voz-235E3eEXiyAcAL6BoHRmj_m5sxHHWm1Q7W3LXu1PL_jvzk1dmNdbqe0D6oH9uJ-FM4K2lZ8K_nx_zd-cf821n-gX-hvwBZ-dxj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1543390806</pqid></control><display><type>article</type><title>Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Tessa, Carlo ; Lucetti, Claudio ; Giannelli, Marco ; Diciotti, Stefano ; Poletti, Michele ; Danti, Sabrina ; Baldacci, Filippo ; Vignali, Claudio ; Bonuccelli, Ubaldo ; Mascalchi, Mario ; Toschi, Nicola</creator><creatorcontrib>Tessa, Carlo ; Lucetti, Claudio ; Giannelli, Marco ; Diciotti, Stefano ; Poletti, Michele ; Danti, Sabrina ; Baldacci, Filippo ; Vignali, Claudio ; Bonuccelli, Ubaldo ; Mascalchi, Mario ; Toschi, Nicola</creatorcontrib><description>The presence of brain atrophy and its progression in early Parkinson's disease (PD) are still a matter of debate, particularly in patients without cognitive impairment. The aim of this longitudinal study was to assess whether PD patients who remain cognitively intact develop progressive atrophic changes in the early stages of the disease. For this purpose, we employed high‐resolution T1‐weighted MR imaging to compare 22 drug‐naïve de novo PD patients without cognitive impairment to 17 age‐matched control subjects, both at baseline and at three‐year follow‐up. We used tensor‐based morphometry to explore the presence of atrophic changes at baseline and to compute yearly atrophy rates, after which we performed voxel‐wise group comparisons using threshold‐free cluster enhancement. At baseline, we did not observe significant differences in regional atrophy in PD patients with respect to control subjects. In contrast, PD patients showed significantly higher yearly atrophy rates in the prefrontal cortex, anterior cingulum, caudate nucleus, and thalamus when compared to control subjects. Our results indicate that even cognitively preserved PD patients show progressive cortical and subcortical atrophic changes in regions related to cognitive functions and that these changes are already detectable in the early stages of the disease. Hum Brain Mapp 35:3932–3944, 2014. © 2014 Wiley Periodicals, Inc.</description><identifier>ISSN: 1065-9471</identifier><identifier>ISSN: 1097-0193</identifier><identifier>EISSN: 1097-0193</identifier><identifier>DOI: 10.1002/hbm.22449</identifier><identifier>PMID: 24453162</identifier><language>eng</language><publisher>New York, NY: Blackwell Publishing Ltd</publisher><subject>Atrophy ; Biological and medical sciences ; Brain - pathology ; brain atrophy ; cognitive status ; de novo PD ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Image Processing, Computer-Assisted ; Imaging, Three-Dimensional ; Investigative techniques, diagnostic techniques (general aspects) ; Longitudinal Studies ; longitudinal study ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Middle Aged ; Nervous system ; Neurology ; Neuropsychological Tests ; Organ Size ; Parkinson Disease - pathology ; Parkinson Disease - psychology ; Radiodiagnosis. Nmr imagery. Nmr spectrometry ; TBM</subject><ispartof>Human brain mapping, 2014-08, Vol.35 (8), p.3932-3944</ispartof><rights>Copyright © 2014 Wiley Periodicals, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6479-a7d0a6962c74ca9db6f1a75bbbfaf33db3dfc6055bb2ddccc1f63aaa63caf99c3</citedby><cites>FETCH-LOGICAL-c6479-a7d0a6962c74ca9db6f1a75bbbfaf33db3dfc6055bb2ddccc1f63aaa63caf99c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868950/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868950/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,27901,27902,45550,45551,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28604490$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24453162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tessa, Carlo</creatorcontrib><creatorcontrib>Lucetti, Claudio</creatorcontrib><creatorcontrib>Giannelli, Marco</creatorcontrib><creatorcontrib>Diciotti, Stefano</creatorcontrib><creatorcontrib>Poletti, Michele</creatorcontrib><creatorcontrib>Danti, Sabrina</creatorcontrib><creatorcontrib>Baldacci, Filippo</creatorcontrib><creatorcontrib>Vignali, Claudio</creatorcontrib><creatorcontrib>Bonuccelli, Ubaldo</creatorcontrib><creatorcontrib>Mascalchi, Mario</creatorcontrib><creatorcontrib>Toschi, Nicola</creatorcontrib><title>Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment</title><title>Human brain mapping</title><addtitle>Hum. Brain Mapp</addtitle><description>The presence of brain atrophy and its progression in early Parkinson's disease (PD) are still a matter of debate, particularly in patients without cognitive impairment. The aim of this longitudinal study was to assess whether PD patients who remain cognitively intact develop progressive atrophic changes in the early stages of the disease. For this purpose, we employed high‐resolution T1‐weighted MR imaging to compare 22 drug‐naïve de novo PD patients without cognitive impairment to 17 age‐matched control subjects, both at baseline and at three‐year follow‐up. We used tensor‐based morphometry to explore the presence of atrophic changes at baseline and to compute yearly atrophy rates, after which we performed voxel‐wise group comparisons using threshold‐free cluster enhancement. At baseline, we did not observe significant differences in regional atrophy in PD patients with respect to control subjects. In contrast, PD patients showed significantly higher yearly atrophy rates in the prefrontal cortex, anterior cingulum, caudate nucleus, and thalamus when compared to control subjects. Our results indicate that even cognitively preserved PD patients show progressive cortical and subcortical atrophic changes in regions related to cognitive functions and that these changes are already detectable in the early stages of the disease. Hum Brain Mapp 35:3932–3944, 2014. © 2014 Wiley Periodicals, Inc.</description><subject>Atrophy</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>brain atrophy</subject><subject>cognitive status</subject><subject>de novo PD</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Imaging, Three-Dimensional</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Longitudinal Studies</subject><subject>longitudinal study</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Organ Size</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson Disease - psychology</subject><subject>Radiodiagnosis. Nmr imagery. Nmr spectrometry</subject><subject>TBM</subject><issn>1065-9471</issn><issn>1097-0193</issn><issn>1097-0193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kt1u1DAQhSMEoqVwwQsgSwgBF2ntOHE2XCCVClpEW4r4k7ixJrazcZvYwXa27BPxmji72-VH4sojzzfnjHycJA8J3icYZwdt3e9nWZ5Xt5JdgqsyxaSit6eaFWmVl2Qnuef9JcaEFJjcTXYiW1DCst3k54Wzc6e819Yg26DagTYIgrNDu0SxDK1CCly3RD7AXPkJugB3pY235qlHUnsFXr1Ah6izZq7DKLWBDgUVAZfWsSdRb93Q2l4FN8mMcqUsFTJ2YdEAQSsTPLrWobVjQMLOjQ56oZDuB9Cuj937yZ0GOq8ebM695POb15-OTtLT98dvjw5PU8HyskqhlBhYxTJR5gIqWbOGQFnUdd1AQ6msqWwEw0W8yaQUQpCGUQBgVEBTVYLuJS_XusNY90qKaO2g44PTPbglt6D53x2jWz63C85mbFYVOAo82wg4-31UPvBee6G6Doyyo-ekyMuCzkg2oY__QS_t6OLjrShKKzzDLFLP15Rw1nunmu0yBPMpfh7j56v4I_voz-235E3eEXiyAcAL6BoHRmj_m5sxHHWm1Q7W3LXu1PL_jvzk1dmNdbqe0D6oH9uJ-FM4K2lZ8K_nx_zd-cf821n-gX-hvwBZ-dxj</recordid><startdate>201408</startdate><enddate>201408</enddate><creator>Tessa, Carlo</creator><creator>Lucetti, Claudio</creator><creator>Giannelli, Marco</creator><creator>Diciotti, Stefano</creator><creator>Poletti, Michele</creator><creator>Danti, Sabrina</creator><creator>Baldacci, Filippo</creator><creator>Vignali, Claudio</creator><creator>Bonuccelli, Ubaldo</creator><creator>Mascalchi, Mario</creator><creator>Toschi, Nicola</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Liss</general><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201408</creationdate><title>Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment</title><author>Tessa, Carlo ; Lucetti, Claudio ; Giannelli, Marco ; Diciotti, Stefano ; Poletti, Michele ; Danti, Sabrina ; Baldacci, Filippo ; Vignali, Claudio ; Bonuccelli, Ubaldo ; Mascalchi, Mario ; Toschi, Nicola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6479-a7d0a6962c74ca9db6f1a75bbbfaf33db3dfc6055bb2ddccc1f63aaa63caf99c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Atrophy</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>brain atrophy</topic><topic>cognitive status</topic><topic>de novo PD</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Imaging, Three-Dimensional</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Longitudinal Studies</topic><topic>longitudinal study</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Organ Size</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson Disease - psychology</topic><topic>Radiodiagnosis. Nmr imagery. Nmr spectrometry</topic><topic>TBM</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tessa, Carlo</creatorcontrib><creatorcontrib>Lucetti, Claudio</creatorcontrib><creatorcontrib>Giannelli, Marco</creatorcontrib><creatorcontrib>Diciotti, Stefano</creatorcontrib><creatorcontrib>Poletti, Michele</creatorcontrib><creatorcontrib>Danti, Sabrina</creatorcontrib><creatorcontrib>Baldacci, Filippo</creatorcontrib><creatorcontrib>Vignali, Claudio</creatorcontrib><creatorcontrib>Bonuccelli, Ubaldo</creatorcontrib><creatorcontrib>Mascalchi, Mario</creatorcontrib><creatorcontrib>Toschi, Nicola</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human brain mapping</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tessa, Carlo</au><au>Lucetti, Claudio</au><au>Giannelli, Marco</au><au>Diciotti, Stefano</au><au>Poletti, Michele</au><au>Danti, Sabrina</au><au>Baldacci, Filippo</au><au>Vignali, Claudio</au><au>Bonuccelli, Ubaldo</au><au>Mascalchi, Mario</au><au>Toschi, Nicola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment</atitle><jtitle>Human brain mapping</jtitle><addtitle>Hum. Brain Mapp</addtitle><date>2014-08</date><risdate>2014</risdate><volume>35</volume><issue>8</issue><spage>3932</spage><epage>3944</epage><pages>3932-3944</pages><issn>1065-9471</issn><issn>1097-0193</issn><eissn>1097-0193</eissn><abstract>The presence of brain atrophy and its progression in early Parkinson's disease (PD) are still a matter of debate, particularly in patients without cognitive impairment. The aim of this longitudinal study was to assess whether PD patients who remain cognitively intact develop progressive atrophic changes in the early stages of the disease. For this purpose, we employed high‐resolution T1‐weighted MR imaging to compare 22 drug‐naïve de novo PD patients without cognitive impairment to 17 age‐matched control subjects, both at baseline and at three‐year follow‐up. We used tensor‐based morphometry to explore the presence of atrophic changes at baseline and to compute yearly atrophy rates, after which we performed voxel‐wise group comparisons using threshold‐free cluster enhancement. At baseline, we did not observe significant differences in regional atrophy in PD patients with respect to control subjects. In contrast, PD patients showed significantly higher yearly atrophy rates in the prefrontal cortex, anterior cingulum, caudate nucleus, and thalamus when compared to control subjects. Our results indicate that even cognitively preserved PD patients show progressive cortical and subcortical atrophic changes in regions related to cognitive functions and that these changes are already detectable in the early stages of the disease. Hum Brain Mapp 35:3932–3944, 2014. © 2014 Wiley Periodicals, Inc.</abstract><cop>New York, NY</cop><pub>Blackwell Publishing Ltd</pub><pmid>24453162</pmid><doi>10.1002/hbm.22449</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1065-9471
ispartof Human brain mapping, 2014-08, Vol.35 (8), p.3932-3944
issn 1065-9471
1097-0193
1097-0193
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6868950
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Atrophy
Biological and medical sciences
Brain - pathology
brain atrophy
cognitive status
de novo PD
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Disease Progression
Female
Follow-Up Studies
Humans
Image Processing, Computer-Assisted
Imaging, Three-Dimensional
Investigative techniques, diagnostic techniques (general aspects)
Longitudinal Studies
longitudinal study
Magnetic Resonance Imaging
Male
Medical sciences
Middle Aged
Nervous system
Neurology
Neuropsychological Tests
Organ Size
Parkinson Disease - pathology
Parkinson Disease - psychology
Radiodiagnosis. Nmr imagery. Nmr spectrometry
TBM
title Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progression%20of%20brain%20atrophy%20in%20the%20early%20stages%20of%20Parkinson's%20disease:%20A%20longitudinal%20tensor-based%20morphometry%20study%20in%20de%20novo%20patients%20without%20cognitive%20impairment&rft.jtitle=Human%20brain%20mapping&rft.au=Tessa,%20Carlo&rft.date=2014-08&rft.volume=35&rft.issue=8&rft.spage=3932&rft.epage=3944&rft.pages=3932-3944&rft.issn=1065-9471&rft.eissn=1097-0193&rft_id=info:doi/10.1002/hbm.22449&rft_dat=%3Cproquest_pubme%3E3365168841%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1543390806&rft_id=info:pmid/24453162&rfr_iscdi=true